TUHR4TKBHomo sapiens (Human)Cancer cell line
Also known as: 4T, 4TUHR, TUHR-4TKB
No AI-generated summary available for this cell line.
Basic Information
| Database ID | CVCL_5957 |
|---|---|
| Species | Homo sapiens (Human) |
| Tissue Source | Kidney[UBERON:UBERON_0002113] |
Donor Information
| Age | 60 |
|---|---|
| Age Category | Adult |
| Sex | Male |
Disease Information
| Disease | Renal cell carcinoma |
|---|---|
| Lineage | Kidney |
| Subtype | Renal Cell Carcinoma |
| OncoTree Code | RCC |
DepMap Information
| Source Type | RIKEN |
|---|---|
| Source ID | ACH-000495_source |
Haplotype Information (STR Profile)
Short Tandem Repeat (STR) profile for cell line authentication.
Loading gene expression data...
Publications
Quantitative proteomics of the Cancer Cell Line Encyclopedia.";
Sellers W.R., Gygi S.P.
Cell 180:387-402.e16(2020).
Next-generation characterization of the Cancer Cell Line Encyclopedia.
Sellers W.R.
Nature 569:503-508(2019).
An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.
Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.
Cancer Res. 79:1263-1273(2019).
Analysis of renal cancer cell lines from two major resources enables genomics-guided cell line selection.
Hsieh J.J.-D., Hakimi A.A.
Nat. Commun. 8:15165.1-15165.10(2017).
TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression.
Loewer M., Sahin U., Castle J.C.
Genome Med. 7:118.1-118.7(2015).
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.
Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.
Nature 483:603-607(2012).
Downregulation of SAV1 plays a role in pathogenesis of high-grade clear cell renal cell carcinoma.
Mimata H., Seto M., Moriyama M.
BMC Cancer 11:523.1-523.10(2011).
Comparative antitumor activity of 5-fluorouracil and 5'-deoxy-5-fluorouridine in combination with interferon-alpha in renal cell carcinoma cell lines.
Nakatani T.
Urol. Int. 73:348-353(2004).
Effects of tumor necrosis factor alpha in renal cell carcinoma.";
Nakatani T.
Oncol. Rep. 10:1947-1955(2003).
Expression of the SART1 tumor rejection antigen in renal cell carcinoma.
Yoshizumi O., Itoh K.
Urol. Res. 28:178-184(2000).